Note: Invea Therapeutics withdrew its IPO plans on March 6, 2026, in a letter to the SEC. The company had filed its S-1 in 2023, but it never disclosed terms. We are a pre-clinical biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases, or IMIDs. Our aim is to develop oral, safe and […]

We provide video compression-based software and hardware products, based on our proprietary VAST video compression coding and decoding algorithms and methods. VAST stands for Video Assured Secure Transmission. (Incorporated in Nevada) Reticulate Micro is a technology company focusing on developing, marketing, and delivering video-compression-based software and hardware products, built on our proprietary and patented Video […]

We intend to search for target acquisitions in the financial services industry in North America. (Incorporated in Nevada)  Larry Swets Jr. is our CEO. Mr. Swets is the founder and managing member of Itasca Financial, an advisory and investment firm. Kyle Cerminara is our chairman. He is the co-founder and CEO of Fundamental Global. (Note: FG Merger […]

We intend to focus our search for a target business in the agriculture sector focused on decarbonization. We intend to focus on ag sector business that may provide opportunities for attractive risk-adjusted returns and benefit from sustainability objectives.(Incorporated in the Cayman Islands) We intend to capitalize on the sponsor entities’ platforms to identify, acquire and […]

(Note: This is NOT an IPO. This is a direct listing. There is no underwriter. Maxim Group is the financial advisor. The stock started trading on NASDAQ on Monday, Oct.23, 2023, opening at $23.01.) We are a real estate technology company with a mission to develop, utilize and commercialize our artificial intelligence (“AI”) focused technology […]

We are a clinical-stage biotechnology company uniquely positioned to advance next-generation potentially curative cell therapies for cancer patients. (Incorporated in Delaware) Our programs, platform technologies and manufacturing strategy are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. A CAR is a protein that has been engineered to modify T cells so they […]

We are a real estate consulting company that identifies and purchases what we believe to be underdeveloped real estate properties (land and/or buildings) and re-sell such properties to real estate developers so that they can redevelop those properties. We do not develop, redevelop or participate in the building or construction of any real properties. We […]

We are a global specialty insurance and reinsurance company founded in Bermuda in 2013. (Incorporated in Bermuda) We harness multiple drivers to create shareholder value. These include diverse underwriting operations supported by proprietary technology and a team of over 500 full-time employees, a strong balance sheet, and a unique investment management relationship with Two Sigma […]

We provide cloud-based payments software for healthcare providers to help them manage their revenue. (Incorporated in Delaware)  Our mission is to simplify healthcare payments through our modern cloud-based software, enabling our healthcare clients to prioritize patient care and optimize their financial performance. Overview Waystar provides healthcare organizations with mission-critical cloud software that simplifies healthcare payments. […]

We are a holding company incorporated in the British Virgin Islands. Our principal Hong Kong subsidiary, mFINANCE Limited, provides an online trading platform for the Asian market. This is known as a Platform as a Service (PaaS). (Incorporated in the British Virgin Islands) m-FINANCE has approximately 20 years of experience providing real-time mission critical forex, […]